Biotherapeutics are a rapidly developing segment of the pharmaceutical business, accounting for over half of all new drug approvals in recent years. Biotherapeutics, often known as biologicals, are medication therapy products in which the active ingredient is derived from a biological source. Biotherapeutics, the fastest-growing group of pharmaceuticals, are used to treat a wide range of chronic and even life-threatening disorders. They cover a wide range of biological products, including nucleic acids, proteins, entire cells, virus particles, and vaccinations. In recent years, significant progress has been made in developing safer and more effective biotherapeutics, as well as adopting cost-effective, more efficient, and streamlined manufacturing processes. As emerging fields such as advanced therapies and personalized medicine nature, this trend is expected to accelerate in the coming years.
Title : Resveratrol derivatives a new tool for osteogenic induction in the treatment of peri implantitis
Barbara De Filippis, University “G. d’Annunzio, Italy
Title : Non-coding RNAs in the cardiovascular disorders linked to Chronic Kidney Disease
Laurent Metzinger, University of Picardie Jules Verne, France
Title : Drugs as an environmental problem chromatographic and computational studies of drugs partition between soil and water
Anna Weronika Sobanska, Medical University of Lodz, Poland
Title : miR-29b inhibition in triple negative cells target apoptosis and autophagy related mechanisms
Cornelia Braicu, Iuliu Haţieganu University of Medicine and Pharmacy, Romania
Title : Synthesis and in vitro study of antiproliferative heterocyclic scaffolds
Hitendra M Patel, Sardar Patel University, India
Title : Mucoadhesive microcapsule: A novel approach for controlling & sustained drug delivery!
Subas Chandra Dinda, Teerthanker Mahaveer University, India